Improving the stability of the EC1 domain of E-cadherin by thiol alkylation of the cysteine residue
Open Access
- 17 April 2012
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 431 (1-2) , 16-25
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Enhancement of Drug Absorption through the Blood−Brain Barrier and Inhibition of Intercellular Tight Junction Resealing by E-Cadherin PeptidesMolecular Pharmaceutics, 2010
- The Role of Covalent Dimerization on the Physical and Chemical Stability of the EC1 Domain of Human E-CadherinJournal of Pharmaceutical Sciences, 2009
- Characterization of Multiple Stable Conformers of the EC5 Domain of E‐cadherin and the Interaction of EC5 with E‐cadherin PeptidesChemical Biology & Drug Design, 2009
- Evaluation of the physical stability of the EC5 domain of E-cadherin: Effects of pH, temperature, ionic strength, and disulfide bondsJournal of Pharmaceutical Sciences, 2009
- Biochemical and structural analysis of α-catenin in cell–cell contactsBiochemical Society Transactions, 2008
- Enhanced Circulating Half-Life and Antitumor Activity of a Site-Specific Pegylated Interferon-α Protein TherapeuticBioconjugate Chemistry, 2007
- Structure and Mechanism of Cadherins and Catenins in Cell-Cell ContactsAnnual Review of Cell and Developmental Biology, 2007
- Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivityExperimental Hematology, 2006
- C-Cadherin Ectodomain Structure and Implications for Cell Adhesion MechanismsScience, 2002
- Circular dichroic study of conformational changes in ovalbumin induced by modification of sulfhydryl groups and disulfide reductionThe Protein Journal, 1989